Skip to main content
SpringerLink
Log in

Patient Population and Selection Criteria for Mechanical Circulatory Support

  • Chapter
  • First Online:
Mechanical Support for Heart Failure

Abstract

Previous data has shown that elective left ventricular assist device (LVAD) implantation in ambulatory advanced heart failure patients can improve event-free survival and quality of life. The patient selection criteria for mechanical circulatory support (MCS) are complex as it involves integrating data from INTERMACS profile, clinical variables, invasive hemodynamic assessment, and recent hospitalization history. Identifying patients before incipient end organ failure ensues is key to prevent irreversible damage prior to LVAD implantation. Specific red flags that should warrant referral for advanced therapies include repeat hospitalizations, medication intolerance, worsening exercise cardiopulmonary stress testing, worsening cardiac hemodynamics, or inotrope dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Bibliography

  1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association WRITING GROUP MEMBERS. 2010 [cited 2018 Nov 14]; Available from: http://www.americanheart.org/presenter.jhtml.

  2. Mehra MR, Jarcho JA, Cherikh W, Vaduganathan M, Lehman RR, Smits J, et al. The Drug-Intoxication Epidemic and Solid-Organ Transplantation. N Engl J Med [Internet]. 2018 May 17 [cited 2019 Feb 12];378(20):1943–5. Available from: http://www.nejm.org/doi/10.1056/NEJMc1802706.

  3. Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report--2007. J Heart Lung Transplant [Internet]. 2007 Aug 1 [cited 2018 Nov 14];26(8):769–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17692781.

  4. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. SPECIAL FEATURE Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients Site and patient enrollment. J Hear Lung Transplant [Internet]. 2013 [cited 2018 Nov 14];32:141–56. Available from: https://doi.org/10.1016/j.healun.2012.12.004.

  5. Ric R Ose EA, Nnetine G Elijns AC, Lan M Oskowitz AJ, Aniel H Eitjan DF, Ynne S Tevenson LW, Alter Embitsky WD, et al. The New England Journal of Medicine. Long-term use of a left ventricular assist device for end-stage heart failure for the r andomized e valuation of m echanical a ssistance for the t reatment of c ongestive h eart failure [Internet]. N Engl J Med. 2001 [cited 2018 Nov 14]. 345. Available from: www.nejm.org.

  6. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte J V, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device abstract. N Engl J Med [Internet]. 2009 [cited 2018 Nov 14];17:2241–51. Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa0909938.

  7. Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC, et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med [Internet]. 2017 Feb 2 [cited 2018 Nov 14];376(5):440–50. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1610426.

  8. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Hear Lung Transplant [Internet]. 2013 Feb 1 [cited 2018 Nov 14];32(2):141–56. Available from: https://www.sciencedirect.com/science/article/pii/S105324981201457X.

  9. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Hear Lung Transplant [Internet]. 2009 Jun 1 [cited 2018 Nov 14];28(6):535–41. Available from: https://www.sciencedirect.com/science/article/pii/S1053249809001910.

  10. Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant [Internet]. 2011 Apr 1 [cited 2018 Dec 3];30(4):402–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21168346.

  11. Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients. J Am Coll Cardiol [Internet]. 2015 Oct 20 [cited 2019 Feb 12];66(16):1747–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26483097.

  12. Starling RC, Estep JD, Horstmanshof DA, Milano CA, Stehlik J, Shah KB, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP Study 2-year results. JACC Hear Fail [Internet]. 2017 Jul 1 [cited 2018 Dec 3];5(7):518–27. Available from: https://www.sciencedirect.com/science/article/pii/S2213177917301646?via%3Dihub.

  13. Solomon SD, Dobson J, Pocock S, Skali H, Mcmurray JJ V, Granger CB, et al. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. 2007 [cited 2018 Dec 3]; Available from: http://circ.ahajournals.org.

  14. Patel PA, Heizer G, O’Connor CM, Schulte PJ, Dickstein K, Ezekowitz JA, et al. Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality findings from ASCEND-HF. Circ Hear Fail. 2014.

    Google Scholar 

  15. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Heart failure influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure findings from the OPTIMIZE-HF program. 2008 [cited 2018 Dec 3]; Available from: https://ac.els-cdn.com/S0735109708015039/1-s2.0-S0735109708015039-main.pdf?_tid=2cc15f30-aac6-4369-b273-66a24ee7b87b&acdnat=1543829242_fb20cc53d8df1395bc4a5533426b7ef7.

  16. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation [Internet]. 1991 Mar [cited 2018 Dec 3];83(3):778–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1999029.

  17. Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Prognosis on chronic dobutamine or milrinone infusions for Stage D Heart Failure. 2009 [cited 2019 Feb 12]; Available from: http://www2.sas.com/proceedings/sugi26/p214-26.pdf.

  18. Bansal N, Hailpern SM, Katz R, Hall YN, Tamura MK, Kreuter W, et al. Outcomes associated with left ventricular assist devices among recipients with and without end-stage renal disease. JAMA Intern Med [Internet]. 2018 Feb 1 [cited 2018 Dec 3];178(2):204. Available from: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2017.4831.

  19. Kim MS, Kato TS, Farr M, Wu C, Givens RC, Collado E, et al. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. J Am Coll Cardiol [Internet]. 2013 Jun 4 [cited 2018 Dec 3];61(22):2253–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23563127.

  20. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the heartmate II risk score. J Am Coll Cardiol [Internet]. 2013 Jan 22 [cited 2019 Feb 12];61(3):313–21. Available from: https://www.sciencedirect.com/science/article/pii/S0735109712055933?via%3Dihub.

  21. Raphael C, Briscoe C, Davies J, Whinnett ZI, Manisty C, Sutton R, et al. Heart failure and cardiomyopathy. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart [Internet]. 2007 [cited 2019 Feb 12];93:476–82. Available from: www.heartjnl.com.

  22. Lanfear DE, Levy WC, Stehlik J, Estep JD, Rogers JG, Shah KB, et al. Accuracy of seattle heart failure model and heartmate II risk score in non–inotrope-dependent advanced heart failure patients. Circ Hear Fail [Internet]. 2017 May [cited 2018 Dec 3];10(5). Available from: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.116.003745.

  23. Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, et al. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail [Internet]. 2017 Jul 1 [cited 2019 Feb 12];19(7):926–46. Available from: http://doi.wiley.com/10.1002/ejhf.733.

  24. Konstam MA, Kiernan MS, Bernstein D, Bozkurt B, Jacob M, Kapur NK, et al. On behalf of the American Heart Association Coun-cil on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on cardiovascular surgery and anesthesia. Circulation [Internet]. 2018 [cited 2019 Feb 12];137:578–622. Available from: http://circ.ahajournals.org.

  25. Yancy CW, Januzzi JL, Allen LA, Butler J, Davis LL, Fonarow GC, et al. 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction. J Am Coll Cardiol [Internet]. 2018 Jan [cited 2019 Feb 12];71(2):201–30. Available from: https://linkinghub.elsevier.com/retrieve/pii/S073510971741641X.

Download references

Author information

Authors and Affiliations

  1. Kaufman Center for Heart Failure, Heart & Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

    Pavan Bhat MD

  2. Kaufman Center for Heart Failure, Cleveland Clinic, Cleveland, OH, USA

    Randall C. Starling MD, MPH, FACC, FAHA, FESC, FHFSA

Authors
  1. Pavan Bhat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Randall C. Starling MD, MPH, FACC, FAHA, FESC, FHFSA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Randall C. Starling MD, MPH, FACC, FAHA, FESC, FHFSA .

Editor information

Editors and Affiliations

  1. Lerner Research Institute, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland Clinic, Cleveland, OH, USA

    Jamshid H. Karimov

  2. Lerner Research Institute, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland Clinic, Cleveland, OH, USA

    Kiyotaka Fukamachi

  3. Kaufman Center for Heart Failure Heart, Thoracic, and Vascular Institute, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University Cleveland Clinic, Cleveland, OH, USA

    Randall C. Starling

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bhat, P., Starling, R.C. (2020). Patient Population and Selection Criteria for Mechanical Circulatory Support. In: Karimov, J., Fukamachi, K., Starling, R. (eds) Mechanical Support for Heart Failure . Springer, Cham. https://doi.org/10.1007/978-3-030-47809-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-47809-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-47808-7

  • Online ISBN: 978-3-030-47809-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation